Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 6.43B | 6.78B | 7.94B | 5.93B | 4.00B |
Gross Profit | 2.46B | 1.90B | 2.32B | 1.85B | 1.31B |
EBITDA | 7.78B | 10.47B | 19.15B | 7.75B | 4.03B |
Net Income | 2.85B | 4.33B | 12.22B | 5.30B | 3.10B |
Balance Sheet | |||||
Total Assets | 62.27B | 65.50B | 71.32B | 53.82B | 36.32B |
Cash, Cash Equivalents and Short-Term Investments | 19.26B | 20.63B | 13.14B | 6.12B | 8.17B |
Total Debt | 16.50B | 16.45B | 16.15B | 8.27B | 3.86B |
Total Liabilities | 20.99B | 20.89B | 21.19B | 12.96B | 6.39B |
Stockholders Equity | 17.87B | 18.96B | 20.58B | 29.19B | 21.75B |
Cash Flow | |||||
Free Cash Flow | 936.00M | -479.00M | -981.00M | -62.00M | -310.00M |
Operating Cash Flow | 1.03B | -177.00M | -702.00M | 73.00M | -196.00M |
Investing Cash Flow | 142.00M | 12.55B | 5.91B | -731.00M | 2.32B |
Financing Cash Flow | -8.24B | -12.10B | 894.00M | 53.00M | 6.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $24.72B | 12.99 | 48.08% | ― | 17.00% | 901.05% | |
78 Outperform | $41.93B | 198.17 | 10.11% | ― | 69.97% | ― | |
75 Outperform | $105.71B | 137.67 | 9.71% | ― | 23.78% | ― | |
75 Outperform | $30.25B | 9.03 | 9.85% | ― | -1.33% | 32.92% | |
72 Outperform | $31.69B | 27.49 | 14.07% | 0.71% | 10.66% | 84.89% | |
67 Neutral | ¥277.38B | 14.70 | 6.81% | 2.50% | 5.06% | -22.84% | |
63 Neutral | $52.19B | 10.43 | 26.41% | 0.21% | 11.29% | 99.24% |